Navigation Links
Phase 3 Clinical Trial Begins in Early Form of Dementia
Date:9/9/2012

MANCHESTER, England, September 10, 2012 /PRNewswire/ --

Investigational drug study follows earlier study with promising results in mild to moderate Alzheimer's patients

TauRx Therapeutics today announced the initiation of a global Phase 3 clinical trial in a type of Frontotemporal Dementia (FTD) also known as Pick's Disease. The announcement, which immediately follows The 8th International Conference on Frontotemporal Dementias, held 5-7 September in Manchester, England, underscores the need for new treatments for this form of dementia that is similar to Alzheimer's Disease, except that it tends to damage different areas of the brain and affects people as early as 40 years old.

The study focuses on a type of FTD known as behavioural-variant, or bvFTD, which can cause early changes in personality and loss of empathy. A large percentage of these patients have a specific pathology that involves abnormal collections of tau protein in the brain.

The study drug, LMTX®, targets a process in the brain whereby a normal form of tau protein begins to self-aggregate due to binding neuronal waste-products. Once the process has started, the aggregates are able to propagate themselves indefinitely, using up normal tau protein and converting it into the toxic aggregates. After destroying the nerve cells where they are initially formed, the aggregates go on to infect nearby healthy neurons, progressively spreading and accelerating the destruction throughout the brain. LMTX® stops this aggregation process in its tracks and releases the trapped tau protein in a form which can be easily cleared by nerve cells.

In a pilot series of cases, LMTX® was found to arrest the progression of the disease. LMTX® has been found to act in a similar way on the aggregation of TDP-43 protein. Tau or TDP-43 aggregates each account for about 50% of patients with this early form of dementia.'/>"/>

SOURCE TauRx Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
2. Lead Therapeutic Candidate for Treatment of Pain from Adynxx, AYX1, Well-Tolerated in Phase 1 Clinical Study
3. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
4. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
5. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
6. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
9. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
10. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
11. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical Textiles, ... VESTEX ® , has recently received two notable innovation ... global competition that recognizes innovations with potential to create ... last night in New York City ... Material Science "Protection & Safety" category. The awards honor ...
(Date:4/24/2015)... Introduction of new ... tools for radiosurgery/SBRT   The "Elements" ... enhancing the workflow for difficult to treat indications ... - comes full circle with the introduction of ... Elements enable on-the-fly generation of consistent treatment plans ...
(Date:4/24/2015)... April 24, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ... developing premium quality medical marijuana products and a licensed ... Medical Purposes Regulations ( Canada ) ("MMPR"), ... of its shareholders, has closed the transaction announced on ... has acquired (the "Escrow Transfer") a total of 20,156,790 ...
Breaking Medicine Technology:VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... GUANGZHOU, China, May 3, 2012 /PRNewswire-Asia/ -- ... announced it has acquired Guangzhou Bioseal Biotechnology ... company specializing in the design, development and ... for controlling bleeding during surgery. The acquisition ...
... 2012 Angioslide Ltd. a provider of ... received FDA 510(K) clearance for its new 3X100mm PROTEUS ... knee (BTK) vasculature.  The new 3/100mm device accommodates 0.014" ... technology.   Angioslide,s proprietary technology combines the ...
Cached Medicine Technology:Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd. 2Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device 2
(Date:4/24/2015)... Will County, Illinois (PRWEB) April 24, 2015 ... 2015 event includes septic tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) ... of 3-customers to start the program. This does not ... may be applicable. Save $25-$65 per person. If someone ... Aerobic/Mechanical unit, or two tanks totaling approximately 2500 gallons ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 The Fastest Fat ... after their great success of the Xtreme Fat Loss Diet, ... The fat loss blueprint that claims to help one ... attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative review. , ... that the creators spent years researching and experimenting with these ...
(Date:4/24/2015)... 2015 The first step to transforming ... , For meditation and yoga teacher Stine Koppernæs, meditation ... invaluable tools that allow her to experience more peace ... been a teacher since 2006, and through the years ... of being. , “I love sharing this way of ...
(Date:4/24/2015)... April 24, 2015 Integrative Therapeutics ... key pathways: immunity and cognition. , A unique ... helps set ProThrivers™ Wellness Flavonoid Complex apart from ... combination of ingredients to support antioxidation versus the ... unites curcumin, green tea extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, ...
(Date:4/24/2015)... Insuranceautoquote.info has released a new blog post explaining how ... Lowering auto insurance prices is not difficult. Clients can ... for their financial budget. Comparing prices by using quotes ... registration. , Comparing quotes can help many drivers ... sell coverage and this means that clients have increased ...
Breaking Medicine News(10 mins):Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2
... of women affected by breast cancer and provide them with ... according to a paper in the November issue of the ... carried out by Dr Maggi Banning, from Brunel University, Uxbridge, ... cancer patients and survivors with better information about the best ...
... How do fetal cells know what cell types to become? ... they are and develop into cancer cells? These are some ... epigenetics. Danish epigenetic research has a very strong position internationally ... from BRIC, University of Copenhagen. She has just received an ...
... SATURDAY, Nov. 5 (HealthDay News) -- Arthritis of the knee ... but shedding a few pounds if you,re overweight may reduce ... at the American College of Rheumatology annual meeting, in Chicago. ... and 84 will receive a diagnosis of knee osteoarthritis in ...
... Nov. 7, 2011 A recent first-of-its-kind survey of ... 75 percent of women reported being done having children, ... OB/GYNs. Without these important patient-physician conversations taking place, the ... permanent birth control options. In particular, the survey showed ...
... Newly published research shows that more patients with ... choose hemodialysis as their initial kidney replacement therapy ... of the study now available in Arthritis ... American College of Rheumatology (ACR), also found that ...
... During the 2009 H1N1 influenza pandemic, many previously ... and respiratory failure, sometimes fatal. The largest nationwide ... children, led by Children,s Hospital Boston, found one ... Staphylococcus aureus (MRSA) increased the risk for ...
Cached Medicine News:Health News:Employers need to tackle culture of ignorance around breast cancer survivors who work 2Health News:Employers need to tackle culture of ignorance around breast cancer survivors who work 3Health News:Research in cellular memory 2Health News:Knee Arthritis Striking at Younger Ages, But Weight Loss May Help 2Health News:Knee Arthritis Striking at Younger Ages, But Weight Loss May Help 3Health News:Landmark survey reveals that most women who are done having children do not discuss their options with their OB/GYNs 2Health News:Landmark survey reveals that most women who are done having children do not discuss their options with their OB/GYNs 3Health News:Most lupus nephritis patients with end-stage renal disease opt for hemodialysis therapy 2Health News:Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic? 2Health News:Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic? 3Health News:Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic? 4
... High-Throughput (HTP) Protein Electrophoresis ... integrated pre-cast gel system ... protein analysis. It consists ... E-Base™ integrated power device, ...
... E-Holder™ Platform is designed with a spring-loaded ... and E-Gel® 48 gel cassettes stay firmly ... reproducible placement and loading from one gel ... adjustments to the robot loading software. In ...
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
... Injection molded chambers are seamless eliminating the ... The Primo tanks have temperature resistant gel ... to pour you gels. For added user friendliness, ... a UV fluorescent rule. The Primo Gel ...
Medicine Products: